Adverse Birth Outcomes in Botswana Among Women With Vertically or Horizontally Acquired Human Immunodeficiency Virus
Open Access
- 3 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 10 (3) , 252-258
Abstract
Background: Women with vertically acquired HIV (VHIV) may have a greater risk of adverse birth outcomes than women with horizontally acquired HIV (HHIV). Methods: The Tsepamo study performed birth outcomes surveillance at 8 government delivery sites in Botswana from July 2014 through March 2019. Pregnant women diagnosed with HIV before their 11th birthday received VHIV status, and other women had HHIV. Small for gestational age (SGA), preterm delivery (PTD), stillbirth, and neonatal death were compared using χ2 and Fisher’s exact tests. Log-binomial regression models determined risk ratios (RRs). Results: VHIV women (n = 402) aged 15–27 years were identified over 4 years of surveillance and compared with HHIV women (n = 8465) of the same age. VHIV women were more likely to use nevirapine (NVP)-based antiretroviral treatment (ART) in pregnancy and to have SGA and very SGA infants, but less likely to have very PTD infants. In unadjusted analyses, VHIV women had a higher risk of any adverse birth outcome combined (RR = 1.21, 95% confidence interval [CI], 1.08–1.36). After adjusting for potential confounders, particularly use of NVP-based regimens, the risk of adverse birth outcomes among VHIV and HHIV women was similar. Conclusions: NVP-based ART is a primary and modifiable risk factor for adverse birth outcomes. Updating ART regimens could improve birth outcomes for women with HIV.Keywords
Funding Information
- National Institutes of Health (R01HD080471)
This publication has 12 references indexed in Scilit:
- Comparative Safety of Antiretroviral Treatment Regimens in PregnancyJAMA Pediatrics, 2017
- Pregnancy incidence and outcomes in women with perinatal HIV infectionAIDS, 2017
- Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 ProtocolClinical Infectious Diseases, 2017
- Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in BotswanaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
- INTERGROWTH-21st very preterm size at birth reference chartsThe Lancet, 2016
- International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st ProjectThe Lancet, 2014
- Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challengesThe Lancet Infectious Diseases, 2014
- Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysisThe Lancet Global Health, 2014
- Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in BotswanaThe Journal of Infectious Diseases, 2012
- The Impact of the Increasing Number of Multiple Births on the Rates of Preterm Birth and Low Birthweight: An International StudyAmerican Journal of Public Health, 2002